IPO Pipeline: Filings begin to trickle in to set the slate for September
NEW FILINGS Company: Bicara Therapeutics, Inc. Symbol: BCAX (Nasdaq) Description: They are a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Shares: TBD Price Range: TBD Trade Date: TBD Underwriters: Morgan Stanley, TD Cowen, Cantor, Stifel Link to Prospectus: Filed: 8-22-24 Company: Zenas BioPharma, Inc. Symbol: ZBIO (Nasdaq)[…]
